Document is current
Any future updates will be listed below
-
Authors
Blazanin, Michael http://orcid.org/0000-0003-4630-6235
Turner, Paul E http://orcid.org/0000-0003-3490-7498
- License Information
-
More Information
Article History
Received: 22 January 2021
Revised: 30 April 2021
Accepted: 11 May 2021
First Online: 14 June 2021
Compliance with ethical standards
:
: MB declares no competing interests. PET is a co-founder of Felix Biotechnology Inc., and declares a financial interest in this company that seeks to commercially develop phages for use as therapeutics.
